Ormeloxifene Suppresses Prostate Tumor Growth and Metastatic Phenotypes via Inhibition of Oncogenic β-catenin Signaling and EMT Progression

Bilal Bin Hafeez(South Dakota State University), Meena Jaggi(The University of Texas Rio Grande Valley), Murali M. Yallapu(The University of Texas Rio Grande Valley), Aditya Ganju(Memorial Sloan Kettering Cancer Center), Nadeem Zafar(University of Tennessee Health Science Center), Vivek K. Kashyap(University of Tennessee Health Science Center), Andrew E. Massey(University of Tennessee Health Science Center), Subhash C. Chauhan(The University of Texas Rio Grande Valley), Neeraj Chauhan(The University of Texas Rio Grande Valley), Manish Tripathi(All India Institute of Medical Sciences), Zubair Bin Hafeez(Jamia Millia Islamia), Man Mohan Singh(Central Drug Research Institute), Shabnam Malik(University of Tennessee Health Science Center), Fathi T. Halaweish(South Dakota State University), Mohammed Sikander(University of Tennessee Health Science Center)
Molecular Cancer Therapeutics
June 14, 2017
Cited by 50


Related Papers